Potassium Citrate
- Product NDC
- 44523-410
- 11-digit product format
- 445230410
- Labeler code
- 44523
- Product ID
- 44523-410_461546fa-70f8-dad0-e063-6394a90a4675
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- potassium citrate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Biocomp Pharma, Inc.
- Application
- NDA019071
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2024-12-03
- Substance
- POTASSIUM CITRATE
- Active strength
- 10 meq/1
- Pharmacologic classes
- Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| EE90ONI6FF | POTASSIUM CITRATE | 6100-05-6 | POTASSIUM CITRATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 44523-410-01 | 44523041001 | 100 TABLET in 1 BOTTLE (44523-410-01) | 100 tablet | 2024-12-03 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Potassium Citrate | Biocomp Pharma, Inc. | Mission Pharmacal Company | 2025-12-16 | HUMAN PRESCRIPTION DRUG LABEL | 11 |